Sector Intelligence
Healthcare & BioTech
The convergence of AI, genomics, and digital health is restructuring healthcare delivery globally. The total market reaches $3.14 trillion by 2030.
$3.14T
Market 2030
$573B
Digital Health
13.1%
CAGR
45%+
AI Diagnostics
Strategic Overview
The Institutional Investment Case
The convergence of AI, genomics, and digital health is structurally reshaping healthcare. Aging populations create demand that transcends economic cycles — making this one of the most recession-resistant investment themes.
Subsector Intelligence
Healthcare & BioTech Subsectors
- AI DiagnosticsMachine learning applied to imaging and early disease detection — outperforming specialists in key categories.45%+ CAGR
- Digital Health PlatformsTelehealth, remote monitoring, chronic disease management — $573B market by 2030.22% CAGR
- Genomics & Precision MedicineGene therapy, CRISPR, personalized oncology — transitioning from research to commercial deployment.31% CAGR
- MedTech & DevicesConnected devices, surgical robotics, continuous monitoring — hardware layer of digital health.14% CAGR
- Healthcare InfrastructureHospital networks, diagnostic chains — capital deploying into emerging market healthcare build-out.12% CAGR
Position Your Healthcare Company for Institutional Capital
The right narrative, the right investors, the right moment. MNSR Capital builds the bridge.
Start the Conversation